TRANSVAC Open Call for Vaccine Development Services

The EU infrastructure project TRANSVAC offers high-quality technical services free of charge to promote the development of prophylactic and therapeutic vaccines for both human and animal use.

TRANSVAC aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal to build an efficient and sustainable collaboration of experts and facilities to catalyse vaccine research in Europe. TRANSVAC seeks to support vaccine-related projects by providing access to the services and expertise available within the TRANSVAC Infrastructure.

The call for application was launched on 15 October 2017 and will remain open for the duration of the project (until April 2022) or until all services have been exhausted. Applications can be submitted at any time and will be processed at pre-defined cut-off dates occurring every four months. The first cut-off date is on 15 December 2017. Academic and non-academic research groups, SMEs and industries are encouraged to apply. Selected projects will then be able to commence work within TRANSVAC shortly after notification.

For more information about the services offered by TRANSVAC, the eligibility criteria and the application process, please visit: